Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Intra-Cellular Therapies, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ITCI is no longer listed, so this page shows Q1 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 395
- +11 vs. Q4 2024
- Shares held
- 103.1M
- +6.87M (+7.1%) vs. Q4 2024
- Total value
- $13.6B
- +$5.56B (+69.2%) vs. Q4 2024
- New holders
- 160
- 88 more added
- Sold out
- 149
- 117 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $2.54K |
| Q1 2026 | 1 | $2.54K |
| Q4 2025 | 1 | $2.54K |
| Q3 2025 | 1 | $2.54K |
| Q2 2025 | 4 | $4.15M |
| Q1 2025 | 395 | $13.6B |
| Q4 2024 | 387 | $8.08B |
| Q3 2024 | 356 | $7.12B |
| Q2 2024 | 376 | $6.62B |
| Q1 2024 | 346 | $6.15B |
| Q4 2023 | 335 | $6.42B |
| Q3 2023 | 294 | $4.54B |
| Q2 2023 | 288 | $5.34B |
| Q1 2023 | 274 | $4.55B |
| Q4 2022 | 283 | $4.41B |
| Q3 2022 | 274 | $3.89B |
| Q2 2022 | 266 | $4.65B |
| Q1 2022 | 241 | $4.94B |
| Q4 2021 | 208 | $3.60B |
| Q3 2021 | 181 | $2.56B |
| Q2 2021 | 187 | $2.74B |
| Q1 2021 | 170 | $2.30B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avantax Advisory Services, Inc. | 0 | $0 | 0.00% | −4,494−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −4,193−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −4,119−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −4,101−100.0% | Sold out |
| Regions Financial Corp | 0 | $0 | 0.00% | −4,025−100.0% | Sold out |
| Resources Investment Advisors, LLC. | 0 | $0 | 0.00% | −3,772−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −3,636−100.0% | Sold out |
| Cyrus J. Lawrence, LLC | 0 | $0 | 0.00% | −3,550−100.0% | Sold out |
| HighPoint Advisor Group LLC | 0 | $0 | 0.00% | −2,245−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −3,388−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −3,388−100.0% | Sold out |
| Barlow Wealth Partners, Inc. | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Henshaw Capital LLC | 0 | $0 | 0.00% | −3,336−100.0% | Sold out |
| Avanza Fonder AB | 0 | $0 | 0.00% | −3,043−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −3,005−100.0% | Sold out |
| PEAK6 LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,840−100.0% | Sold out |
| Fulton Bank, N.A. | 0 | $0 | 0.00% | −2,802−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −2,622−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,567−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −2,450−100.0% | Sold out |
| Bryn Mawr Trust Co | 0 | $0 | 0.00% | −2,069−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1,421−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −424−100.0% | Sold out |
| Atwood & Palmer Inc | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −549−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −543−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −282−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −188−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −161−100.0% | Sold out |
| Colonial Trust Co | 0 | $0 | 0.00% | −143−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Cassady Schiller Wealth Management, LLC | – | – | – | – | Not filed |